Marker Therapeutics
MRKR
MRKR
31 hedge funds and large institutions have $11.9M invested in Marker Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+4
Holders Change %
+14.81%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
8
Reduced
7
Closed
3
Calls
$349K
Puts
–
Net Calls
+$349K
Net Calls Change
+$349K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.7M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$330K |
| 3 |
Millennium Management
New York
|
+$315K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$125K |
| 5 |
RI
RTW Investments
New York
|
+$88K |
Top Sellers
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.14M |
| 2 |
6CM
683 Capital Management
New York
|
-$905K |
| 3 |
State Street
Boston,
Massachusetts
|
-$191K |
| 4 |
DLHL
Donald L. Hagan LLC
Sarasota,
Florida
|
-$94K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$46.8K |
